Print

AtriCure, Inc. (ATRC) to Present at the Leerink Swann and Company 2013 Global Healthcare Conference  
2/1/2013 6:50:04 AM

AtriCure, Inc. (Nasdaq: ATRC), a medical device company and a leader in cardiac surgical ablation systems for the treatment of atrial fibrillation, or AF, and systems for the exclusion of the left atrial appendage, today announced that it will present at the Leerink Swann 2013 Global Healthcare Conference at the Waldorf Astoria Hotel in New York on Thursday, February 14, 2013. Management is scheduled to present at 2:30 p.m. Eastern Time.
//-->